Biochemical Assays Archives - Page 2 of 8

Discovery of CVN636: A Highly Potent, Selective, and CNS Penetrant mGluR7 Allosteric Agonist

The metabotropic glutamate receptor mGluR7 is widely expressed throughout the CNS and has been implicated in numerous CNS disorders. WuXi...

Discovery of Novel GST Inhibitors Identified from a DNA-Encoded Library

WuXi AppTec scientists recently contributed to a study which led to the discovery and optimization of a novel series of...

One Stop Target-to-Hit Platform: PIK3CA–PIK3R1

Within the PI3K family, the heterodimer protein comprising the p110-α and p85-α catalytic/regulatory subunits (encoded by PIK3CA and PIK3R1) are...

One Stop Target-to-Hit Platform: Protein arginine methyltransferase 5 (PRMT5)

Protein arginine methyltransferase 5 (PRMT5) is an enzyme which plays an essential role in a wide range of cellular processes. ...

One Stop Target-to-Hit Platform: Cyclin-dependent kinase 2 (CDK2)

Cyclin-dependent kinase 2 (CDK2) and its respective cyclin E1 and cyclin A2 complexes are essential to driving abnormal growth processes...

One Stop Target-to-Hit Platform: Werner Syndrome Helicase (WRN)

Werner syndrome helicase (WRN) is a key drug target for cancers with microsatellite instability. To support the discovery of potent...

Oncolytic Virus Platform

Oncolytic viruses (OVs) are emerging as a promising therapeutic approach for treating cancer. OVs are capable of both tumor-specific cell...

Discovery and preclinical profile of LX-039, a novel indole-based oral selective estrogen receptor degrader (SERD)

WuXi AppTec scientists contributed to a study which identified a novel, indole-based, selective estrogen receptor degrader (SERD), designated LX-039. The authors...

Inhibition of the hERG potassium ion channel by non-nucleoside CMV polymerase antiviral inhibitors

WuXi AppTec scientists collaborated on a study to characterize a series of pyrroloquinoline derivatives that were designed and synthesized to...

Knowledge Library

Discovery of CVN636: A Highly Potent, Selective, and CNS Penetrant mGluR7 Allosteric Agonist

Discovery of Novel GST Inhibitors Identified from a DNA-Encoded Library

One Stop Target-to-Hit Platform: PIK3CA–PIK3R1

One Stop Target-to-Hit Platform: Protein arginine methyltransferase 5 (PRMT5)

One Stop Target-to-Hit Platform: Cyclin-dependent kinase 2 (CDK2)

One Stop Target-to-Hit Platform: Werner Syndrome Helicase (WRN)

Oncolytic Virus Platform

Discovery and preclinical profile of LX-039, a novel indole-based oral selective estrogen receptor degrader (SERD)

Inhibition of the hERG potassium ion channel by non-nucleoside CMV polymerase antiviral inhibitors

Contact An Expert Today!

Discovery of CVN636: A Highly Potent, Selective, and CNS Penetrant mGluR7 Allosteric Agonist

Discovery of Novel GST Inhibitors Identified from a DNA-Encoded Library

One Stop Target-to-Hit Platform: PIK3CA–PIK3R1

One Stop Target-to-Hit Platform: Protein arginine methyltransferase 5 (PRMT5)

One Stop Target-to-Hit Platform: Cyclin-dependent kinase 2 (CDK2)

One Stop Target-to-Hit Platform: Werner Syndrome Helicase (WRN)

Oncolytic Virus Platform

Discovery and preclinical profile of LX-039, a novel indole-based oral selective estrogen receptor degrader (SERD)﻿

Inhibition of the hERG potassium ion channel by non-nucleoside CMV polymerase antiviral inhibitors

Contact An Expert Today!

Discovery and preclinical profile of LX-039, a novel indole-based oral selective estrogen receptor degrader (SERD)